BG63874B1 - Производни на индол-2,3-дион-3-оксим - Google Patents

Производни на индол-2,3-дион-3-оксим Download PDF

Info

Publication number
BG63874B1
BG63874B1 BG102489A BG10248998A BG63874B1 BG 63874 B1 BG63874 B1 BG 63874B1 BG 102489 A BG102489 A BG 102489A BG 10248998 A BG10248998 A BG 10248998A BG 63874 B1 BG63874 B1 BG 63874B1
Authority
BG
Bulgaria
Prior art keywords
methyl
dione
phenyl
oxime
isoquinoline
Prior art date
Application number
BG102489A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102489A (en
Inventor
Frank Waetjen
Jorgen Drejer
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of BG102489A publication Critical patent/BG102489A/xx
Publication of BG63874B1 publication Critical patent/BG63874B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG102489A 1996-10-01 1998-05-26 Производни на индол-2,3-дион-3-оксим BG63874B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK106996 1996-10-01
DK127796 1996-11-13
PCT/DK1997/000418 WO1998014447A1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives

Publications (2)

Publication Number Publication Date
BG102489A BG102489A (en) 1999-04-30
BG63874B1 true BG63874B1 (bg) 2003-04-30

Family

ID=26065167

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102489A BG63874B1 (bg) 1996-10-01 1998-05-26 Производни на индол-2,3-дион-3-оксим

Country Status (29)

Country Link
US (3) US6124285A (pt)
EP (1) EP0869958B1 (pt)
JP (1) JP3319762B2 (pt)
KR (1) KR100492052B1 (pt)
CN (1) CN1093859C (pt)
AT (1) ATE286052T1 (pt)
AU (1) AU716435B2 (pt)
BG (1) BG63874B1 (pt)
BR (1) BR9706765A (pt)
CA (1) CA2238410C (pt)
CZ (1) CZ297938B6 (pt)
DE (1) DE69732090T2 (pt)
DK (1) DK0869958T3 (pt)
EE (1) EE9800144A (pt)
ES (1) ES2235253T3 (pt)
HK (1) HK1017682A1 (pt)
HU (1) HU225145B1 (pt)
IL (1) IL124563A (pt)
IS (1) IS2123B (pt)
NO (1) NO310722B1 (pt)
NZ (1) NZ330456A (pt)
PL (1) PL193041B1 (pt)
PT (1) PT869958E (pt)
RU (1) RU2190612C2 (pt)
SI (1) SI0869958T1 (pt)
SK (1) SK282729B6 (pt)
TR (1) TR199800956T1 (pt)
UA (1) UA54403C2 (pt)
WO (1) WO1998014447A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
DE69922936T2 (de) * 1998-03-31 2005-12-08 Neurosearch A/S Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten
ATE420636T1 (de) 1999-05-19 2009-01-15 Painceptor Pharma Corp Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen
CN1298704C (zh) * 2000-01-24 2007-02-07 神经研究公司 具有神经营养活性的靛红衍生物
IT1318636B1 (it) * 2000-07-21 2003-08-27 Roberto Pellicciari Derivati dell'acido 2- o 3- tenoico ad attivita' antagonista deirecettori del glutammato.
EP1361878A1 (en) * 2001-02-15 2003-11-19 Neurosearch A/S Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
JP2005522408A (ja) 2001-07-13 2005-07-28 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 5−HT受容体リガントとしてのヘキサヒドロアゼピノ(4,5−g)インドールおよびインドリン
JP2006503011A (ja) * 2002-08-22 2006-01-26 ニューロサーチ、アクティーゼルスカブ インドール−2,3−ジオン−3−オキシム誘導体の対掌体の製造方法
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
CA2630617C (en) * 2005-11-23 2014-03-25 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20080004306A1 (en) * 2006-04-10 2008-01-03 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20080021034A1 (en) * 2006-04-10 2008-01-24 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2008031831A2 (en) * 2006-09-12 2008-03-20 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20080108622A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
US20080108603A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
WO2010104324A2 (ko) * 2009-03-10 2010-09-16 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도
CN102653538A (zh) * 2011-03-04 2012-09-05 爱斯医药科技(南京)有限公司 Spd-502的制备方法
AU2016255434C1 (en) 2015-04-29 2021-09-23 Rapport Therapeutics, Inc. Azabenzimidazoles and their use as AMPA receptor modulators
CA2984305C (en) * 2015-04-29 2021-12-28 Janssen Pharmaceutica Nv Indolone compounds and their use as ampa receptor modulators
WO2016176457A1 (en) 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
AU2016255424B2 (en) 2015-04-29 2020-10-08 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2076948C (en) * 1991-08-28 2002-04-16 Frank Watjen Isatineoxime derivatives, their preparation and use
US5721230A (en) 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
ATE161259T1 (de) * 1993-05-13 1998-01-15 Neurosearch As Ampa antagonisten und behandlungsmethode
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
US5917053A (en) * 1994-09-14 1999-06-29 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives, their preparation and use
DE69514533T2 (de) * 1994-09-14 2000-07-06 Neurosearch A/S, Ballerup Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму

Also Published As

Publication number Publication date
JP3319762B2 (ja) 2002-09-03
CZ160698A3 (cs) 1998-10-14
US6693111B1 (en) 2004-02-17
JP2000501432A (ja) 2000-02-08
CN1093859C (zh) 2002-11-06
IS2123B (is) 2006-07-14
US6124285A (en) 2000-09-26
BR9706765A (pt) 1999-09-14
RU2190612C2 (ru) 2002-10-10
BG102489A (en) 1999-04-30
HU225145B1 (en) 2006-07-28
CA2238410A1 (en) 1998-04-09
PL193041B1 (pl) 2007-01-31
MX9804365A (es) 1998-10-31
CN1207100A (zh) 1999-02-03
IL124563A0 (en) 1998-12-06
KR19990071823A (ko) 1999-09-27
PL327073A1 (en) 1998-11-23
EE9800144A (et) 1998-10-15
ATE286052T1 (de) 2005-01-15
NO982466L (no) 1998-07-31
SK282729B6 (sk) 2002-11-06
PT869958E (pt) 2005-05-31
CZ297938B6 (cs) 2007-05-02
DE69732090T2 (de) 2005-12-29
SI0869958T1 (en) 2005-06-30
AU4376897A (en) 1998-04-24
NO310722B1 (no) 2001-08-20
DK0869958T3 (da) 2005-04-18
USRE38200E1 (en) 2003-07-22
ES2235253T3 (es) 2005-07-01
UA54403C2 (uk) 2003-03-17
NO982466D0 (no) 1998-05-29
DE69732090D1 (de) 2005-02-03
SK67698A3 (en) 1998-11-04
CA2238410C (en) 2007-06-12
TR199800956T1 (xx) 1998-12-21
NZ330456A (en) 1998-11-25
HK1017682A1 (en) 1999-11-26
IL124563A (en) 2005-05-17
EP0869958B1 (en) 2004-12-29
KR100492052B1 (ko) 2005-09-30
WO1998014447A1 (en) 1998-04-09
EP0869958A1 (en) 1998-10-14
HUP9901630A2 (hu) 1999-08-30
IS4748A (is) 1998-05-18
HUP9901630A3 (en) 2001-11-28
AU716435B2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
BG63874B1 (bg) Производни на индол-2,3-дион-3-оксим
DK174161B1 (da) Anellerede indolderivater, fremgangsmåde til deres fremstilling og fremgangsmåde til fremstilling af farmaceutisk præparat indeholdende dem
WO2007005887A2 (en) Androgen receptor modulator compounds, compositions and uses thereof
US7595336B2 (en) Isatine derivatives with neurotrophic activity
JPH08510221A (ja) Ampa拮抗薬およびそれを用いての治療方法
JPH03200786A (ja) ラクタム誘導体
EP1066037B1 (en) Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
EP1140855A1 (en) Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
NZ293265A (en) 5-aryl-isoquinoline-2-one-3-acyloxime derivatives fused with a n-heterocyclic ring
MXPA98004365A (en) Novel indole-2,3-dione-3-oxime derivatives